SOMMY OTC
Sumitomo Chemical Company, Limited
1W: +0.7%
1M: -3.9%
3M: +12.6%
YTD: +28.9%
1Y: +15.5%
3Y: +39.0%
5Y: -23.1%
$18.61
+0.26 (+1.39%)
Weekly Expected Move ±6.0%
$16
$17
$19
$20
$21
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2.47T
-5.3% ▼
5Y CAGR: +1.5%
Gross Profit
$708.6B
-2.3% ▼
5Y CAGR: -1.7%
Operating Income
$109.0B
-43.6% ▼
5Y CAGR: -4.9%
Net Income
$64.6B
+67.5% ▲
5Y CAGR: +7.0%
EPS (Diluted)
$196.55
+66.7% ▲
5Y CAGR: +6.9%
EBITDA
$237.3B
-30.7% ▼
5Y CAGR: -2.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $2.77T | $2.90T | $2.45T | $2.61T | $2.47T |
| YoY Growth | +20.9% | +4.7% | -15.5% | +6.5% | -5.3% |
| Cost of Revenue | $1.52T | $2.07T | $1.95T | $1.88T | $1.76T |
| Gross Profit | $873.9B | $820.9B | $499.7B | $725.5B | $708.6B |
| Gross Margin | 31.6% | 28.4% | 20.4% | 27.8% | 28.7% |
| R&D Expenses | $171.9B | $195.6B | $0 | $0 | $0 |
| SG&A Expenses | $466.7B | $629.7B | $887.1B | $601.1B | $599.6B |
| Operating Expenses | $621.6B | $878.3B | $988.5B | $532.4B | $599.6B |
| Operating Income | $183.0B | -$57.3B | -$488.8B | $193.0B | $109.0B |
| Operating Margin | 6.6% | -2.0% | -20.0% | 7.4% | 4.4% |
| Interest Expense | $23.1B | $39.6B | $47.0B | $152.6B | $67.6B |
| Income Before Tax | $251.1B | $231M | -$462.8B | $58.1B | $123.1B |
| Tax Expense | $64.7B | $47.1B | $2.7B | $15.4B | $706M |
| Net Income | $162.1B | $7.0B | -$311.8B | $38.6B | $64.6B |
| Net Margin | 5.9% | 0.2% | -12.7% | 1.5% | 2.6% |
| EPS (Diluted) | $495.80 | $21.35 | $-953.45 | $117.90 | $196.55 |
| EBITDA | $338.2B | $110.6B | -$258.3B | $342.3B | $237.3B |
| Shares Outstanding | 327M | 327M | 327M | 327M | 328M |